TY - JOUR
T1 - Urushiol Patch Test Using the T.R.U.E. TEST System
AU - Kim, Yesul
AU - Longenecker, Amy
AU - Elsohly, Mahmoud A.
AU - Gul, Waseem
AU - Hage, Raymond J.
AU - Hamann, Curtis P.
AU - Marks, James G.
N1 - Publisher Copyright:
© 2018 American Contact Dermatitis Society. All Rights Reserved.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Background Poison ivy, poison oak, and poison sumac are the most common causes of allergic contact dermatitis in North America. Although extensive efforts have been made to develop therapies that prevent and treat allergic contact dermatitis to these plants, there lacks an entirely effective method, besides complete avoidance. Efforts to develop a more effective preventive therapy, such as a vaccine, are ongoing. To accurately evaluate the efficacy of these new therapies, an appropriate assessment tool is needed. Objective The aim of this study was to evaluate the safety and appropriate doses of urushiol required for a patch test based on the hydrogel delivery system of the Thin-Layer Rapid Use Epicutaneous Patch Test. Methods Nine subjects were patch tested with various doses of urushiol and a negative control on day 0. Patch test sites were inspected for any local reaction on days 2, 4, 7, 14, and 21 after the initial exposure and graded by standard morphology. Conclusions All 9 subjects did not have any significant adverse effects. The urushiol patch test using the hydrogel delivery method demonstrated urushiol sensitivity. All doses of urushiol resulted in a local reaction, and severity of reactions was correlated with dosage of urushiol used in the patch test.
AB - Background Poison ivy, poison oak, and poison sumac are the most common causes of allergic contact dermatitis in North America. Although extensive efforts have been made to develop therapies that prevent and treat allergic contact dermatitis to these plants, there lacks an entirely effective method, besides complete avoidance. Efforts to develop a more effective preventive therapy, such as a vaccine, are ongoing. To accurately evaluate the efficacy of these new therapies, an appropriate assessment tool is needed. Objective The aim of this study was to evaluate the safety and appropriate doses of urushiol required for a patch test based on the hydrogel delivery system of the Thin-Layer Rapid Use Epicutaneous Patch Test. Methods Nine subjects were patch tested with various doses of urushiol and a negative control on day 0. Patch test sites were inspected for any local reaction on days 2, 4, 7, 14, and 21 after the initial exposure and graded by standard morphology. Conclusions All 9 subjects did not have any significant adverse effects. The urushiol patch test using the hydrogel delivery method demonstrated urushiol sensitivity. All doses of urushiol resulted in a local reaction, and severity of reactions was correlated with dosage of urushiol used in the patch test.
UR - http://www.scopus.com/inward/record.url?scp=85047186323&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047186323&partnerID=8YFLogxK
U2 - 10.1097/DER.0000000000000360
DO - 10.1097/DER.0000000000000360
M3 - Article
C2 - 29762206
AN - SCOPUS:85047186323
SN - 1710-3568
VL - 29
SP - 127
EP - 131
JO - Dermatitis
JF - Dermatitis
IS - 3
ER -